Armata Pharmaceuticals (ARMP) Other Non Operating Income (2013 - 2026)

Armata Pharmaceuticals has reported Other Non Operating Income for 14 years, with the latest figure at -$101.1 million in Q1 2026.

• Quarterly Other Non Operating Income fell 2042.38% year-over-year to -$101.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$236.8 million (down 705.22% YoY) and the FY2025 annual result came in at -$121.0 million, down 614.3% from the prior year.
• Other Non Operating Income improved to -$101.1 million in Q1 2026 per ARMP's latest filing, from -$121.2 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $23.4 million in Q2 2024 and troughed at -$121.2 million in Q4 2025.
• A 5-year average of -$13.1 million and a median of $9000.0 in 2022 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 121540.0% in 2023, down 314500.0% in 2023.
• Over 5 years, Other Non Operating Income stood at $14000.0 in 2022, then slumped by 168671.43% to -$23.6 million in 2023, then surged by 126.46% to $6.2 million in 2024, then sank by 2041.38% to -$121.2 million in 2025, then grew by 16.63% to -$101.1 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$101.1 million, -$121.2 million, and -$14.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.